Key stats
About Future Health Care Equity ETF
Home page
Inception date
Nov 9, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Goldman Sachs Asset Management LP
Distributor
ALPS Distributors, Inc.
ISIN
US38149W7700
GDOC targets innovators and disruptors in the healthcare sector by looking for companies that are developing new treatments and technologies, primarily in the following key themes: genomics, precision medicine, tech-enabled procedures, and digital healthcare. Eligible companies are not required to derive any current or future revenue from healthcare innovation. GDOC may invest in foreign issuers and in any market capitalization. It may use other funds, futures, forwards, and options to gain its desired exposure. The funds key themes and their respective allocations may vary over time, depending on the fund advisers discretion. The fund adviser utilizes a fundamental investment process that may integrate ESG factors with fundamental metrics. Company disclosure, third-party research, engagement with companies, and subjective criteria are used by the fund adviser to form investment decisions.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.61%
Health Technology90.93%
Health Services3.06%
Technology Services2.65%
Distribution Services1.97%
Bonds, Cash & Other1.39%
Mutual fund1.39%
Stock breakdown by region
North America78.44%
Europe17.30%
Asia4.27%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
GDOC invests in stocks. The fund's major sectors are Health Technology, with 90.93% stocks, and Health Services, with 3.06% of the basket. The assets are mostly located in the North America region.
GDOC top holdings are Eli Lilly and Company and Boston Scientific Corporation, occupying 9.39% and 7.94% of the portfolio correspondingly.
GDOC last dividends amounted to 0.01 USD. The year before, the issuer paid 0.18 USD in dividends, which shows a 3.01 K% decrease.
GDOC assets under management is 19.42 M USD. It's fallen 4.68% over the last month.
GDOC fund flows account for −1.64 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, GDOC pays dividends to its holders with the dividend yield of 0.02%. The last dividend (Dec 30, 2024) amounted to 0.01 USD. The dividends are paid annually.
GDOC shares are issued by The Goldman Sachs Group, Inc. under the brand Goldman Sachs. The ETF was launched on Nov 9, 2021, and its management style is Active.
GDOC expense ratio is 0.75% meaning you'd have to pay 0.75% of your investment to help manage the fund.
GDOC follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
GDOC invests in stocks.
GDOC price has fallen by −0.11% over the last month, and its yearly performance shows a −10.64% decrease. See more dynamics on GDOC price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.18% over the last month, showed a 4.13% increase in three-month performance and has decreased by −10.57% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.18% over the last month, showed a 4.13% increase in three-month performance and has decreased by −10.57% in a year.
GDOC trades at a premium (0.02%) meaning the ETF is trading at a higher price than the calculated NAV.